Avalon GloboCare’s Subsidiary Files Third U.S. Provisional Patent for its Catch-Up Generative AI Video Platform

Core Viewpoint - Avalon GloboCare Corp. has filed a U.S. provisional patent application for an AI-driven system that generates multiple personalized commentary video variants while maintaining factual integrity [1][2]. Group 1: Patent Details - The provisional patent application is titled "Systems and Methods for Audience-Adaptive Generation of Evidence-Preserving Commentary Video Variants" [2]. - The technology addresses limitations in automated content systems that typically provide uniform commentary across diverse audiences or prioritize engagement over factual accuracy [2]. Group 2: System Functionality - The system analyzes audience engagement data, topic preferences, and viewer characteristics to create audience profiles [3]. - It generates customized video variants that can differ in structure, emphasis, tone, pacing, and presentation style, while adhering to predefined evidence rules to ensure factual consistency [3]. Group 3: Performance and Applications - Performance data from each version is continuously collected to refine future content strategies [4]. - Potential applications include personalized financial commentary, sports highlight recaps, and brand-safe marketing content tailored for specific audience segments and distribution channels [4][5]. Group 4: Company Overview - Avalon GloboCare Corp. focuses on developing precision diagnostic consumer products and generative AI publishing and software [6]. - The company is currently marketing the KetoAir™ breathalyzer device, which is registered as a Class I medical device with the U.S. FDA [6].